The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Assembly Biosciences Inc
F:V7B
|
US |
|
Brookfield Corp
F:K7X
|
CA |
|
F
|
Friwo AG
SWB:CEA
|
DE |
|
C
|
Carlisle Companies Inc
XMUN:CLE
|
US |
|
Amesite Inc
NASDAQ:AMST
|
US |
|
E
|
Empresas Copec SA
SGO:COPEC
|
CL |
|
Eagers Automotive Ltd
ASX:APE
|
AU |
|
S
|
Scentre Group
F:59S
|
AU |
|
M
|
Mosaic Co
F:02M
|
US |
|
K
|
Kinross Gold Corp
F:KIN2
|
CA |
|
C
|
Casella Waste Systems Inc
F:WA3
|
US |
|
4
|
4C Group AB
F:K0E
|
SE |
|
Valartis Group AG
LSE:0RPP
|
CH |
|
W
|
Weir Group PLC
F:42W
|
UK |
|
Brioschi Sviluppo Immobiliare SpA
MIL:BRI
|
IT |
|
Valeo SE
PAR:FR
|
FR |
|
P
|
Public Storage
SWB:PUP
|
US |
|
W
|
Whitbread PLC
OTC:WTBCF
|
UK |
|
A
|
ANI Pharmaceuticals Inc
F:BSFA
|
US |
|
A
|
Aciselsan Acipayam Seluloz Sanayi ve Ticaret AS
IST:ACSEL.E
|
TR |
|
Dogness International Corp
NASDAQ:DOGZ
|
CN |
|
Dexus
F:0DPS
|
AU |
|
Organizacion Soriana SAB de CV
F:OSOB
|
MX |
|
First Mining Gold Corp
TSX:FF
|
CA |
Assembly Biosciences Inc (V7B)’s 12-month stock price forecast through November 2027 has a consensus target of €61.92, implying 245% upside. The forecast is based on price targets from 8 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
V7B is 61.92 EUR with a low forecast of 50.7 EUR and a high forecast of 76 EUR.
The compound annual growth rate for Revenue over the next 8 years is 20%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more